Early treatments for COVID-19
The 5,710 treatments below have been reported as potentially beneficial for COVID-19. We currently review studies for:
acetaminophen
adintrevimab
alkalinization
antiandrogens
aspirin
bamlanivimab/etesevimab
bebtelovimab
bromhexine
budesonide
cannabidiol
casirivimab/imdevimab
cetylpyridinium chloride
chlorhexidine
colchicine
convalescent plasma
curcumin
diet
ensitrelvir
ensovibep
exercise
famotidine
favipiravir
fluvoxamine
HCQ
hydrogen peroxide
ibuprofen
indomethacin
iota-carrageenan
ivermectin
lactoferrin
melatonin
metformin
molnupiravir
N-acetylcysteine
nigella sativa
nitazoxanide
nitric oxide
paxlovid
peginterferon lambda
phthalocyanine
povidone-iodine
probiotics
proxalutamide
quercetin
remdesivir
selenium
sleep
sotrovimab
spironolactone
sunlight
tixagevimab/cilgavimab
vitamin A
vitamin B12
vitamin B9
vitamin C
vitamin D
zinc
The following papers report potential benefits of 5,653
other treatments. We have not reviewed these studies.
Sort by number of studies
Sort alphabetically
Submit updates
Please send us corrections, updates, or comments.
c19early involves the extraction of over 100,000 datapoints from
thousands of papers. Community updates
help ensure high accuracy.
Vaccines and treatments are complementary. All practical, effective, and safe
means should be used based on risk/benefit analysis. No treatment, vaccine, or
intervention is 100% available and effective for all current and future
variants. We do not provide medical advice. Before taking any medication,
consult a qualified physician who can provide personalized advice and details
of risks and benefits based on your medical history and situation. FLCCC and WCH
provide treatment protocols.
Thanks for your feedback! Please search before submitting papers and note
that studies are listed under the date they were first available, which may be
the date of an earlier preprint.